Ann: Phase I Clinical Trial Dosing Update No 3, page-18

  1. 868 Posts.
    lightbulb Created with Sketch. 426
    Benooodly, nothing I've said is incorrect. It's great you're enthusiastic about NYR, and I am too. But there is no need to ramp.

    1. Any NYR phase 2 results are not likely to be released this year or next year. For example, ARG's phase 2 was approved in Q3 2023, with expected readout Q3 2025. So best estimate for NYR phase 2 results is sometime in 2027 / 2028.

    2. Even if your $7m in funding is correct, that's not enough to fund a phase 2. ARG have raised maybe $20m in that period, from memory?

    3. "82 percent protection is not a partial response" - I'm not quite sure what to say. 100% is a complete response.... anything less is a partial response? And again, this is not in humans!

    4. ??





 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
24.0¢
Change
0.015(6.67%)
Mkt cap ! $50.62M
Open High Low Value Volume
22.5¢ 24.0¢ 22.5¢ $120.9K 510K

Buyers (Bids)

No. Vol. Price($)
1 20000 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 81970 1
View Market Depth
Last trade - 15.58pm 30/06/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.